Literature DB >> 12202667

Palliative chemotherapy or watchful waiting? A vignettes study among oncologists.

C G Koedoot1, J C J M De Haes, S H Heisterkamp, P J M Bakker, A De Graeff, R J De Haan.   

Abstract

PURPOSE: To determine the preferences of oncologists for palliative chemotherapy or watchful waiting and the factors considered important to that preference.
METHODS: Sixteen vignettes (paper case descriptions), varying on eight patient and treatment characteristics, were designed to assess the oncologists' preferences. Their strength of preference was rated on a 7-point scale. An orthogonal main effects design provided a subset of all possible combinations of the characteristics, allowing estimations of the relative weights of the presented characteristics. A written questionnaire was sent to a random sample of oncologists (N = 1,235).
RESULTS: The response rate was 67%, and 697 questionnaires were available for analysis. Eighty-one percent of the respondents were male. The mean age was 46 years. We found considerable variation among the oncologists. No major associations between physician characteristics and preferences were found. Of the patient and treatment characteristics affecting treatment preference, age was the strongest predictor, followed by the patient's wish to be treated and the expected survival gain. Other patient and treatment characteristics had a limited effect on preferences, except for psychologic distress, which had no independent impact.
CONCLUSION: Patients will encounter different decisions depending on their oncologists' preferences and their own personal background. Therefore, to ensure adequate information for decision-making processes, decision aids are proposed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202667     DOI: 10.1200/JCO.2002.12.012

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  15 in total

1.  How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.

Authors:  E B Moth; B E Kiely; V Naganathan; A Martin; P Blinman
Journal:  Support Care Cancer       Date:  2017-08-03       Impact factor: 3.603

2.  Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists.

Authors:  D Hui; S Bansal; M Park; A Reddy; J Cortes; F Fossella; E Bruera
Journal:  Ann Oncol       Date:  2015-06-03       Impact factor: 32.976

3.  Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.

Authors:  Regina Gironés; Dolores Torregrosa; José Gómez-Codina; Inma Maestu; Jose María Tenias; Rafael Rosell
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

4.  Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?

Authors:  Clarissa Seródio Baldotto; Eduardo Henrique Cronemberger; Paulo de Biasi; Mauro Zamboni; Aureliano Sousa; Mauro Zukin; Isabelle A Small; Carlos Gil Ferreira
Journal:  Support Care Cancer       Date:  2012-02-10       Impact factor: 3.603

5.  Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model.

Authors:  David Hui; Ahmed Elsayem; Zhijun Li; Maxine De La Cruz; J Lynn Palmer; Eduardo Bruera
Journal:  Cancer       Date:  2010-04-15       Impact factor: 6.860

Review 6.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

7.  Chemotherapy with low-dose capecitabine as palliative treatment in a patient with metastatic breast cancer: a case report.

Authors:  Takashi Kawaguchi; Satoru Iwase; Hironori Takeuchi; Ayako Ikeda; Yujiro Kuroda; Naoko Sakata; Megumi Umeda; Kaori Kobara; Tadaharu Matsunaga; Sakae Unezaki; Yoshinori Nagumo
Journal:  Cases J       Date:  2009-11-24

8.  Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes.

Authors:  Joshua A Salomon; Ajay Tandon; Christopher J L Murray
Journal:  BMJ       Date:  2004-01-23

9.  'Being there' for women with metastatic breast cancer: a pan-European patient survey.

Authors:  V Harding; M Afshar; J Krell; R Ramaswami; C J Twelves; J Stebbing
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

10.  Development and validation of the Japanese version of the Decisional Conflict Scale to investigate the value of pharmacists' information: a before and after study.

Authors:  Takashi Kawaguchi; Kanako Azuma; Takuhiro Yamaguchi; Hiroshi Soeda; Yusuke Sekine; Masayoshi Koinuma; Hironori Takeuchi; Takao Akashi; Sakae Unezaki
Journal:  BMC Med Inform Decis Mak       Date:  2013-04-17       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.